Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Correspondence] Remediating “Lessons from the controversy over statins”

Richard Horton’s Offline Comment1 (Sept 10, p 1040) refers to the paper we published in The BMJ2 as “disputed research and tendentious opinions about statin use among people at low risk of cardiovascular disease”, but fails to report that the primary analysis and conclusion in our article have not been disputed. Rather, the conclusion of the 2012 Cholesterol Treatment Trialists (CTT) meta-analysis3 that “In individuals with 5-year risk of major vascular events lower than 10%, each 1 mmol/L reduction in LDL cholesterol produced an absolute reduction in major vascular events of about 11 per 1000 over 5 years” is what is disputed.

email